These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22444677)

  • 21. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists.
    Worm K; Weaver DG; Green RC; Saeui CT; Dulay DM; Barker WM; Cassel JA; Stabley GJ; DeHaven RN; LaBuda CJ; Koblish M; Brogdon BL; Smith SA; Dolle RE
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5004-8. PubMed ID: 19646869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and the 5-HT6 receptor antagonistic effect of 3-arylsulfonylamino-5,6-dihydro-6-substituted pyrazolo[3,4]pyridinones for neuropathic pain treatment.
    Devegowda VN; Hong JR; Cho S; Lim EJ; Choo H; Keum G; Rhim H; Nam G
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4696-700. PubMed ID: 23820387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Alkylidenearylcarboxamides as new potent and selective CB(2) cannabinoid receptor agonists with good oral bioavailability.
    Ohta H; Ishizaka T; Tatsuzuki M; Yoshinaga M; Iida I; Tomishima Y; Toda Y; Saito S
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6299-304. PubMed ID: 17884496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands: structural insights into the design of a novel inverse agonist series.
    El Bakali J; Muccioli GG; Renault N; Pradal D; Body-Malapel M; Djouina M; Hamtiaux L; Andrzejak V; Desreumaux P; Chavatte P; Lambert DM; Millet R
    J Med Chem; 2010 Nov; 53(22):7918-31. PubMed ID: 20979417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Millan J; Derocq JM; Casellas P; Congy C; Oustric D; Sarran M; Bouaboula M; Calandra B; Portier M; Shire D; Brelière JC; Le Fur GL
    J Pharmacol Exp Ther; 1998 Feb; 284(2):644-50. PubMed ID: 9454810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Oxo-1,4-dihydropyridines as selective CB₂ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.
    El Bakali J; Gilleron P; Body-Malapel M; Mansouri R; Muccioli GG; Djouina M; Barczyk A; Klupsch F; Andrzejak V; Lipka E; Furman C; Lambert DM; Chavatte P; Desreumaux P; Millet R
    J Med Chem; 2012 Oct; 55(20):8948-52. PubMed ID: 23017078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists.
    Morales-Ramos ÁI; Li YH; Hilfiker M; Mecom JS; Eidam P; Shi D; Tseng PS; Brooks C; Zhang D; Wang N; Jaworski JP; Morrow D; Fries H; Edwards R; Jin J
    Bioorg Med Chem Lett; 2011 May; 21(10):2806-11. PubMed ID: 21514150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.
    Ando M; Sato N; Nagase T; Nagai K; Ishikawa S; Takahashi H; Ohtake N; Ito J; Hirayama M; Mitobe Y; Iwaasa H; Gomori A; Matsushita H; Tadano K; Fujino N; Tanaka S; Ohe T; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem; 2009 Aug; 17(16):6106-22. PubMed ID: 19616955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
    Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.
    Markt P; Feldmann C; Rollinger JM; Raduner S; Schuster D; Kirchmair J; Distinto S; Spitzer GM; Wolber G; Laggner C; Altmann KH; Langer T; Gertsch J
    J Med Chem; 2009 Jan; 52(2):369-78. PubMed ID: 19143566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity.
    Ermann M; Riether D; Walker ER; Mushi IF; Jenkins JE; Noya-Marino B; Brewer ML; Taylor MG; Amouzegh P; East SP; Dymock BW; Gemkow MJ; Kahrs AF; Ebneth A; Löbbe S; O'Shea K; Shih DT; Thomson D
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1725-9. PubMed ID: 18255291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
    Stern E; Muccioli GG; Millet R; Goossens JF; Farce A; Chavatte P; Poupaert JH; Lambert DM; Depreux P; Hénichart JP
    J Med Chem; 2006 Jan; 49(1):70-9. PubMed ID: 16392793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitors.
    Xu J; Wei L; Mathvink R; Edmondson SD; Mastracchio A; Eiermann GJ; He H; Leone JF; Leiting B; Lyons KA; Marsilio F; Patel RA; Petrov A; Wu JK; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1346-9. PubMed ID: 16332437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.
    Giblin GM; Billinton A; Briggs M; Brown AJ; Chessell IP; Clayton NM; Eatherton AJ; Goldsmith P; Haslam C; Johnson MR; Mitchell WL; Naylor A; Perboni A; Slingsby BP; Wilson AW
    J Med Chem; 2009 Oct; 52(19):5785-8. PubMed ID: 19743867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
    Rhee MH; Vogel Z; Barg J; Bayewitch M; Levy R; Hanus L; Breuer A; Mechoulam R
    J Med Chem; 1997 Sep; 40(20):3228-33. PubMed ID: 9379442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.
    Muccioli GG; Wouters J; Scriba GK; Poppitz W; Poupaert JH; Lambert DM
    J Med Chem; 2005 Nov; 48(23):7486-90. PubMed ID: 16279809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microwave-assisted synthesis of quinoline, isoquinoline, quinoxaline and quinazoline derivatives as CB2 receptor agonists.
    Saari R; Törmä JC; Nevalainen T
    Bioorg Med Chem; 2011 Jan; 19(2):939-50. PubMed ID: 21215643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.